Tower Research Capital LLC (TRC) - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 72 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.6%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$7,000
-53.3%
2,083
-41.6%
0.00%
Q1 2022$15,000
-63.4%
3,569
-59.2%
0.00%
-100.0%
Q4 2021$41,000
+95.2%
8,752
+64.1%
0.00%0.0%
Q3 2021$21,000
-25.0%
5,332
-18.9%
0.00%0.0%
Q2 2021$28,000
-17.6%
6,576
-17.9%
0.00%0.0%
Q1 2021$34,000
+41.7%
8,012
+25.9%
0.00%0.0%
Q4 2020$24,000
-72.7%
6,362
-70.7%
0.00%0.0%
Q3 2020$88,000
-17.0%
21,680
-13.3%
0.00%
-75.0%
Q2 2020$106,000
+221.2%
25,011
+197.8%
0.00%
+33.3%
Q4 2019$33,0008,399
+14898.2%
0.00%
Q3 2019$0
-100.0%
56
-15.2%
0.00%
Q2 2019$1,000
-96.7%
66
-98.6%
0.00%
-100.0%
Q1 2019$30,000
-64.7%
4,574
+7.9%
0.00%
-66.7%
Q3 2018$85,000
-77.7%
4,241
-67.0%
0.01%
-81.8%
Q1 2018$382,000
+453.6%
12,833
+545.5%
0.03%
+450.0%
Q3 2017$69,000
+475.0%
1,988
+404.6%
0.01%
+500.0%
Q2 2017$12,000
-55.6%
394
-57.2%
0.00%
-66.7%
Q1 2017$27,000
+80.0%
921
+5.9%
0.00%
+50.0%
Q4 2016$15,000
-11.8%
870
+22.4%
0.00%0.0%
Q3 2016$17,000
-54.1%
711
-69.2%
0.00%
-50.0%
Q2 2016$37,000
+516.7%
2,306
+902.6%
0.00%
+300.0%
Q4 2015$6,000
-72.7%
230
-70.7%
0.00%
-50.0%
Q3 2015$22,0000.0%784
-13.1%
0.00%0.0%
Q2 2015$22,000902
+3658.3%
0.00%
Q1 2015$0
-100.0%
24
-20.0%
0.00%
Q4 2014$1,000
-66.7%
30
-89.2%
0.00%
Q3 2014$3,000
-50.0%
278
-48.7%
0.00%
-100.0%
Q1 2014$6,0005420.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2016
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders